TPX-0046 is a novel and potent RET/SRC inhibitor for RET-driven cancers - Concepedia

Concepedia

Publication | Closed Access

TPX-0046 is a novel and potent RET/SRC inhibitor for RET-driven cancers

55

Citations

0

References

2019

Year

Alexander Drilon, Evan Rogers, Dayong Zhai, Wei Deng, X. Zhang, D. Lee, Jane Ung, Jeffrey Whitten, H. Zhang, Jialiang Liu,

Annals of Oncology

Tumor BiologyOncologyPotent Ret/src InhibitorMedicineAnti-cancer AgentTumor SuppressorCancer TreatmentPharmacologyCell BiologyRet-driven CancersNovel TherapyCancer Research

No additional data available for this publication yet. Check back later!